Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Colonoscopy
Interventions
DRUG

BLI800 - Dose 1

BLI800 oral solution

DRUG

BLI800 - Dose 2

BLI800 oral solution

Trial Locations (5)

Unknown

Arkansas Children's Hospital Research Institute, Little Rock

Children's Center for Digestive Health Care, Atlanta

Delta Research Partners, Bastrop

Gastrointestinal Associates, Jackson

University of Buffalo Pediatric Associates, Buffalo

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY